TMO Thermo Fisher Scientific Inc

  1. Stocks
  2. Healthcare
  3. NYSE: TMO

Price (delayed)

$593.37

Market cap

$233.82B

P/E Ratio

27.33

Dividend/share

$1.04

EPS

$21.71

Enterprise value

$243.5B

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry . ...

Highlights
TMO's EPS has soared by 77% year-on-year
Thermo Fisher Scientific's net income has soared by 76% YoY
The stock's price to earnings (P/E) is 14% less than its 5-year quarterly average of 31.7 but 8% more than its last 4 quarters average of 25.4
The debt has increased by 16% QoQ and by 2.9% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.thermofisher.com/
Peers: PKI BDX WAT BIO

Key stats

What are the main financial stats of TMO
Market
Shares outstanding
394.05M
Market cap
$233.82B
Enterprise value
$243.5B
Valuations
Price to earnings (P/E)
27.33
Price to book (P/B)
6.03
Price to sales (P/S)
5.99
EV/EBIT
23.44
EV/EBITDA
18.88
EV/Sales
6.23
Earnings
Revenue
$39.06B
EBIT
$10.39B
EBITDA
$12.9B
Free cash flow
$7.93B
Per share
EPS
$21.71
Free cash flow per share
$20.12
Book value per share
$98.39
Revenue per share
$99.13
TBVPS
$88.23
Balance sheet
Total assets
$73.6B
Total liabilities
$34.89B
Debt
$21.71B
Equity
$38.71B
Working capital
$16.97B
Liquidity
Debt to equity
0.56
Current ratio
3.19
Quick ratio
2.27
Net debt/EBITDA
0.75
Margins
EBITDA margin
33%
Gross margin
51.1%
Net margin
21.9%
Operating margin
27%
Efficiency
Return on assets
12.4%
Return on equity
23.6%
Return on invested capital
31.1%
Return on capital employed
15.8%
Return on sales
26.6%
Dividend
Dividend yield
0.18%
DPS
$1.04
Payout ratio
4.8%

TMO stock price

How has the Thermo Fisher Scientific stock price performed over time
Intraday
0.55%
1 week
-5.09%
1 month
-8.86%
1 year
16.95%
YTD
-11.07%
QTD
-11.07%

Financial performance

How have Thermo Fisher Scientific's revenue and profit performed over time
Revenue
$39.06B
Gross profit
$19.94B
Operating income
$10.56B
Net income
$8.57B
Gross margin
51.1%
Net margin
21.9%
The operating income has soared by 77% YoY
Thermo Fisher Scientific's net income has soared by 76% YoY
Thermo Fisher Scientific's gross profit has increased by 48% YoY
Thermo Fisher Scientific's revenue has increased by 37% YoY and by 2.1% from the previous quarter

Growth

What is Thermo Fisher Scientific's growth rate over time

Valuation

What is Thermo Fisher Scientific stock price valuation
P/E
27.33
P/B
6.03
P/S
5.99
EV/EBIT
23.44
EV/EBITDA
18.88
EV/Sales
6.23
TMO's EPS has soared by 77% year-on-year
The stock's price to earnings (P/E) is 14% less than its 5-year quarterly average of 31.7 but 8% more than its last 4 quarters average of 25.4
The P/B is 51% above the 5-year quarterly average of 4.0 and 12% above the last 4 quarters average of 5.4
The company's equity rose by 22% YoY and by 5% QoQ
Thermo Fisher Scientific's revenue has increased by 37% YoY and by 2.1% from the previous quarter
The P/S is 33% above the 5-year quarterly average of 4.5 and 11% above the last 4 quarters average of 5.4

Efficiency

How efficient is Thermo Fisher Scientific business performance
TMO's return on invested capital has surged by 63% year-on-year but it is down by 3.7% since the previous quarter
TMO's ROA has soared by 55% YoY but it is down by 3.9% from the previous quarter
The ROE has grown by 45% YoY but it has contracted by 5% from the previous quarter
TMO's ROS is up by 28% year-on-year but it is down by 2.9% since the previous quarter

Dividends

What is TMO's dividend history
Dividend details
DPS
$1.04
Dividend yield
0.18%
Payout ratio
4.8%
Recent dividends

Financial health

How did Thermo Fisher Scientific financials performed over time
The total assets is 111% greater than the total liabilities
Thermo Fisher Scientific's quick ratio has increased by 26% from the previous quarter and by 11% YoY
The current ratio has increased by 15% since the previous quarter and by 9% year-on-year
The debt is 44% lower than the equity
The company's equity rose by 22% YoY and by 5% QoQ
The debt has increased by 16% QoQ and by 2.9% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.